Salidroside ameliorates pathological cardiac hypertrophy via TLR4‐TAK1‐dependent signaling
Sign Up to like & getrecommendations! Published in 2022 at "Phytotherapy Research"
DOI: 10.1002/ptr.7701
Abstract: Salidroside, a prominent active ingredient in traditional Chinese medicines, is garnering increased attention because of its unique pharmacological effects against ischemic heart disease via MAPK signaling, which plays a critical role in regulating the evolution… read more here.
Keywords: hypertrophy; jnk p38; tak1; tlr4 ... See more keywords